Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Japanese researchers present positive findings in Synsorb Pk trial

Nov. 27, 1998

New treatment for aldosterone-related disorders discovered by French research team

Nov. 24, 1998

Dual 5alpha-reductase inhibitors and alpha1-blocking agents prepared at Zeria

Nov. 23, 1998

Agents for nephritis in the Tsumura pipeline

Nov. 19, 1998

Dutasteride outshines finasteride in BPH Rx

Nov. 18, 1998

OPC-21268 improves glomerulonephritis in hypercholesterolemic rats, nephropathy in diabetic rats

Nov. 13, 1998

Vasopressin V2 receptor antagonist beneficial in mouse model of PKD

Nov. 13, 1998

VPA-985 characterized as potent, selective, orally active V2 antagonist

Nov. 13, 1998

Sepracor announces results of phase II pilot trial for (S)-oxybutynin

Nov. 13, 1998

RenaGel available this month in the U.S.

Nov. 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...